Where We Stand: AMCP supports the use of therapeutic interchange programs as a part of a comprehensive approach to quality, cost‐effective patient care.
A retrospective claims review published in JMCP found that switching or discontinuing biologics in patients with psoriasis resulted in higher health care utilization and overall medical costs.
A retrospective claims review published in JMCP found that switching or discontinuing biologics in patients with psoriasis resulted in higher health care utilization and overall medical costs.
A retrospective study in JMCP found that pharmacist-adjudicated prior authorization drug requests result in substantial economic benefit, and the prevention of adverse events.
Partnership Forum: This Forum brought together industry leaders to consider P&T practices that reflect the current health care system and provide recommendations to allow for a transparent P&T process in today’s health care system.
A retrospective study in JMCP found that pharmacist-adjudicated prior authorization drug requests result in substantial economic benefit, and the prevention of adverse events.